1. Known etiology of TIA or stroke.

2. Untreated hyperthyroidism.

3. Myocardial infarction less than 1 month prior to stroke or TIA.

4. Coronary bypass grafting less than 1 month prior to stroke or TIA.

5. Valvular disease requiring immediate surgical intervention.

6. History of AF or atrial flutter.

7. Patent Foramen Ovale (PFO) and PFO is or was an indication to start oral anticoagulation (OAC).

8. Permanent indication for OAC at enrollment.

9. Permanent contra-indication for OAC.

10. Included in another clinical trial.

11. Life expectancy less than 1 year.

12. Pregnant.

13. Indicated for Implantable Pulse Generator (IPG), Implantable Cardioverter-Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT) or an implantable hemodynamic monitoring system.

14. Not fit, unable or unwilling to follow the required procedures of the protocol.

Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke

What this study is about